Kolexia
Kerbrat Pierre Oncologie médicale
Kerbrat Pierre
Oncologie médicale
Centre Eugène Marquis
Rennes, France
114 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Récidive tumorale locale Tumeurs embryonnaires et germinales Métastase tumorale Sarcomes Métastase lymphatique Cardiopathies Seconde tumeur primitive

Collaborateurs

Voir plus
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France
Pierga Jean-Yves
Pierga Jean-Yves
Clcc Institut Curie, Paris, France
Ferrero Jean Marc
Ferrero Jean Marc
Centre Antoine Lacassagne, Nice, France
Rios Maria
Rios Maria
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France

Industries

Voir plus
IMS Medical Radar
2 collaboration(s)
Dernière en 2017
STETHOS
1 collaboration(s)
Dernière en 2017
Pierre Fabre
1 collaboration(s)
Dernière en 2017
Roche
1 collaboration(s)
Dernière en 2017

Dernières activités

Voir plus
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors: A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors
Essai Clinique (Unicancer)   01 février 2024
SOFT: A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women With Endocrine Responsive Breast Cancer
Essai Clinique (ETOP IBCSG Partners Foundation)   14 décembre 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   09 août 2023
CANTO: A Cohort to Quantify and to Predict Treatment Related Chronic Toxicities in Patients With Non-metastatic Cancer - Breast and Lung.
Essai Clinique (Unicancer)   20 avril 2023
713P Assessment of bleomycin pulmonary toxicity in men with poor-prognosis non-seminomatous germ-cell tumors treated in the GETUG 13 phase III trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years.
Journal of adolescent and young adult oncology   08 novembre 2019
Beverly1: Phase II Study Evaluating the Efficacy and Tolerance of Bevacizumab (Avastin) in HER2- Inflammatory Breast Cancer
Essai Clinique (Unicancer)   18 octobre 2019
Recommandations françaises de stratégies thérapeutiques pour la prévention et le traitement de l’ostéoporose induite par les traitements adjuvants du cancer du sein
Revue du rhumatisme (Ed. francaise : 1993)   01 octobre 2019
French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies.
Joint bone spine   25 juillet 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Lancet (London, England)   06 juin 2019